Chief Executive Officer of Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Kauffman Michael, sells 9,495 shares worth $140,822
According to Karyopharm Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 22 08:09 PM, company Chief Executive Officer, Kauffman Michael disclosed selling 9,495 shares at a cost of $14.83. At the time of this transaction (Feb 18), this trade was worth $140,822 in total. As of Feb 18, Kauffman Michael now owns 776,452 shares in total worth about $11,584,663.84.
For the last few recent trades made by Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Chief Executive Officer, Kauffman Michael, we have the following information:
- SEC Form 4 filing: Feb 11: Sold 6,601 shares at the rate of $15.52 per share. Total worth of this trade was $102,441. Total number of shares owned as of Feb 11 were 562,821
- SEC Form 4 filing: Feb 11: Sold 6,642 shares at the rate of $15.52 per share. Total worth of this trade was $103,077. Total number of shares owned as of Feb 11 were 764,147
- SEC Form 4 filing: Oct 12: Sold 7,500 shares at the rate of $14.89 per share. Total worth of this trade was $111,683. Total number of shares owned as of Oct 12 were 756,489
Posted by
George Daniels
on Monday February 22 2021, 11:58 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
